[Functional constipation: prospective study and treatment response]

C Martínez-Costa1, M J Palao Ortuño, B Alfaro Ponce

  • 1Servicio de Pediatría, Hospital Clínico, Universidad de Valencia, España. ceciliam@comv.es

Insights

Functional constipation (FC) affects 13% of pediatric consultations, with encopresis in 31%. Treatment success in children with FC depends on regular toilet habits, dietary changes, and family support.

Area of Science:

  • Pediatric Gastroenterology
  • Child Health
  • Digestive Disorders

Background:

  • Functional constipation (FC) is a common pediatric condition.
  • Understanding its prevalence, contributing factors, and treatment outcomes is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence of functional constipation (FC) in children, with or without encopresis.
  • To identify factors contributing to the onset of FC.
  • To evaluate the treatment response for FC in pediatric patients.

Main Methods:

  • A prospective study involving 62 children diagnosed with FC.
  • Utilized standard questionnaires for onset age, toilet habits, encopresis, diet, and psychosocial factors.
  • Physical assessment and anthropometry were performed; treatment involved demystification, behavioral modification, mineral oil, and senna.

Main Results:

  • FC represented 13% of initial pediatric consultations, with a mean age of diagnosis at 6.1 years.
  • Common symptoms included painful defecation (60%), rectorrhagia (42%), and obstructive episodes (34%).
  • Encopresis was present in 31% of patients; 60% had deficient fiber intake.

Conclusions:

  • Successful treatment of FC in children is strongly linked to establishing regular toilet habits, implementing dietary modifications, and fostering positive family attitudes.
  • Treatment efficacy improved over time, with 85% achieving satisfactory results within 6-12 months.
  • Early intervention and a multidisciplinary approach are key to managing pediatric functional constipation.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...